A 10-year retrospective survival study investigated the use of "Pan-Asian medicine & vitamins" as therapy in a case series (n=239) of non-small lung cancer patients. The investigation compared short-term treatment with long-term treatment (duration lasting time span of chemotherapy/radiotherapy and beyond conventional Tx). Comparisons also included Pan-Asian medicine & vitamins plus conventional therapy with conventional therapy alone. Results of the study suggest that there are survival advantages and benefits of using Pan-Asian medicine and vitamins combined with conventional therapy.
This comprehensive and novel research was completed by Pine Street's Clinical Director, Michael Broffman, and Research Director, Michael McCulloch.
View the entire article and abstract @ the Pine Street Foundation: (McCulloch et al., 2011)
Pine Street Foundation
No comments:
Post a Comment